Pure and Applied Chemistry, 2011, Volume 83, No. 11, pp. 2027-2040, References

Pure Appl. Chem., 2011, Vol. 83, No. 11, pp. 2027-2040

http://dx.doi.org/10.1351/PAC-CON-11-01-06

Published online 2011-08-27

Chitosan nanoparticles for tamoxifen delivery and cytotoxicity to MCF-7 and Vero cells

Neralakere Ramanna Ravikumara^1,2 and Basavaraj Madhusudhan²*

¹ Department of Biochemistry, P.G. Centre, Kuvempu University, Shivagangothri, Davanagere 577 002, Karnataka, India
² Research Center for Nanoscience and Technology, Department of Biochemistry and Food Technology, Davanagere University, Shivagangothri, Davanagere 577 002, Karnataka, India

References

1. J. I. MacGregor, V. C. Jordan. Pharmacol. Res. 50, 151 (1998).
2. R. M. O’Regan, V. C. Jordan. Lancet Oncol. 3, 207 (2002). (http://dx.doi.org/10.1016/S1470-2045(02)00711-8)
3. S. G. Pappas, V. C. Jordan. Cancer Metastasis Rev. 21, 311 (2002). (http://dx.doi.org/10.1023/A:1021219212638)
4. T. J. Powles. Eur. J. Cancer. 39, 572 (2003). (http://dx.doi.org/10.1016/S0959-8049(02)00771-2)
5. C. Peters-Engl, W. Frank, E. Danmayr, H. P. Friedl, S. Leodolter, M. Medl. Breast Cancer Res. Treat. 54, 255 (1999). (http://dx.doi.org/10.1023/A:1006126411210)
6. I. Cohen. Gynecol. Oncol. 94, 256 (2004). (http://dx.doi.org/10.1016/j.ygyno.2004.03.048)
7. G. R. de Lima, G. Facina, J. Y. Shida, M. B. C. Chein, P. Tanaka, R. C. Dardes, V. C. Jordan, L. H. Gebrim. Eur. J. Cancer 39, 891 (2003). (http://dx.doi.org/10.1016/S0959-8049(02)00530-0)
8. J. S. Chawla, M. M. Amiji. Int. J. Pharm. 249, 127 (2002). (http://dx.doi.org/10.1016/S0378-5173(02)00483-0)
9. Y. H. Bae, K. M. Huh, Y. Kim, K. Park. J. Controlled Release 64, 3 (2000). (http://dx.doi.org/10.1016/S0168-3659(99)00126-1)
10. H. Ge, Y. Hu, X. Jiang, D. Cheng, Y. Yuan, H. Bi, C. Yang. J. Pharm. Sci. 91, 1463 (2002). (http://dx.doi.org/10.1002/jps.10143)
11. M. N. V. Ravi Kumar. React. Funct. Polym. 46, 1 (2000). (http://dx.doi.org/10.1016/S1381-5148(00)00038-9)
12. K. T. Hwang, S. T. Jung, G. D. Lee, M. S. Chinnan, Y. S. Park, H. J. Park. J. Agric. Food Chem. 50, 1876 (2002). (http://dx.doi.org/10.1021/jf011167u)
13. P. Calvo, C. Remunan-Lopez, J. L. Vila-Jato, M. J. Alonso. J. Appl. Polym. Sci. 63, 125 (1998). (http://dx.doi.org/10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4)
14. M. Prabaharan, J. F. Mano. Drug Deliv. 12, 41 (2005). (http://dx.doi.org/10.1080/10717540590889781)
15. H. D. Soule, J. Vazquez, A. Long, S. Albert, M. Brennan. J. Natl. Cancer Inst. 51, 1409 (1973).
16. A. S. Levenson, V. C. Jordan. Cancer Res. 57, 3071 (1997).
17. N. O. Bianchi, J. Ayres. Exp. Cell Res. 68, 253 (1971). (http://dx.doi.org/10.1016/0014-4827(71)90149-2)
18. V. R. Haas, A. R. Santos Jr., M. L. F. Wada. Cytobios. 106, 255 (2001).
19. J. Knapczyk, L. Krowczynski, J. Krzek, M. Brzeski, E. Nurnberg, D. Schenk, H. Struszczyk, G. S. Braek, T. P. Anthonsen, P. A. Sandford. “Requirements of chitosan for pharmaceutical and biomedical application”, in Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications, pp. 657–663, Elsevier Science, New York (1989).
20. P. Calvo, C. Remuñan-López, J. L. Vila-Jato, M. J. Alonso. Pharm. Res. 14, 1431 (1997). (http://dx.doi.org/10.1023/A:1012128907225)
21. N. R. Ravikumara, T. S. Nagaraj, R. Hiremat Shobharani, G. Raina, B. Madhusudhan. J. Biomater. Appl. 24, 47 (2009). (http://dx.doi.org/10.1177/0885328209103406)
22. T. Mosmann. J. Immunol. Methods 95, 55 (1993).
23. G. Liu, L. Shao, F. Ge, J. Chen. China Particuology 5, 384 (2007). (http://dx.doi.org/10.1016/j.cpart.2007.08.002)
24. I. Bravo-Osuna, G. Millotti, C. Vauthier, G. Ponchel. Int. J. Pharm. 338, 284 (2007). (http://dx.doi.org/10.1016/j.ijpharm.2007.01.039)
25. D. R. Bhumkar, V. B. Pokharkar. AAPS Pharm. Sci. Tech. 7, E1 (2006). (http://dx.doi.org/10.1208/pt070250)
26. Y. Xu, Y. Du. Int. J. Pharm. 250, 215 (2003). (http://dx.doi.org/10.1016/S0378-5173(02)00548-3)
27. F. S. Kittur, K. V. Harish Prashanth, K. Udaya Sankar, R. N. Tharanathan. Carbohydr. Polym. 49, 185 (2002). (http://dx.doi.org/10.1016/S0144-8617(01)00320-4)
28. J. Autian, R. L. Kronenthal, Z. Oser, E. Martin (Eds.). “Biodegradable polymers in medicine and surgery”, in Polymers in Medicine and Surgery, pp. 181–203, Plenum Press, New York (1975).
29. X. Li, R. Li, X. Qian, Y. Ding, Y. Tu, R. Guo, Y. Hu. Eur. J. Pharm. Biopharm. 70, 726 (2008). (http://dx.doi.org/10.1016/j.ejpb.2008.06.016)
30. R. K. Dey, A. R. Ray. Biomaterials 24, 2985 (2003). (http://dx.doi.org/10.1016/S0142-9612(03)00122-4)
31. R. K. Dey, A. R. Ray. J. Appl. Polym. Sci. 90, 4068 (2003).
32. S. C. W. Richardson, H. V. J. Kolbe, R. Duncan. Int. J. Pharm. 178, 231 (1999). (http://dx.doi.org/10.1016/S0378-5173(98)00378-0)
33. L. Zhang, Y. Hu, X. Jiang, C. Yang, W. Lu, Y. Yang. J. Controlled Release 119, 153 (2007). (http://dx.doi.org/10.1016/j.jconrel.2007.02.013)
34. L. Zhang, Y. Hu, X. Jiang, C. Yang, W. Lu, Y. Yang. J. Controlled Release 96, 135 (2004). (http://dx.doi.org/10.1016/j.jconrel.2004.01.010)
35. D. Le Garrec, S. Gori, L. Luo, D. Lessard, D. C. Smith, M. A. Yessine, M. Ranger. J. Controlled Release 99, 83 (2004). (http://dx.doi.org/10.1016/j.jconrel.2004.06.018)
36. E. van Vlerken, Z. Duan, M. V. Seiden, M. M. Amiji. Cancer Res. 67, 4843 (2007). (http://dx.doi.org/10.1158/0008-5472.CAN-06-1648)
37. T. S. Bekaii-Saab, M. A. Villalona-Calero. Semin. Oncol. 32, S3 (2005). (http://dx.doi.org/10.1053/j.seminoncol.2005.04.002)

Pure and Applied Chemistry

Navigation

PAC Archives

RSS Feeds

Highlights

Chitosan nanoparticles for tamoxifen delivery and cytotoxicity to MCF-7 and Vero cells

References

Pure and Applied Chemistry

Navigation

Search PAC

PAC Archives

RSS Feeds

Highlights

Chitosan nanoparticles for tamoxifen delivery and cytotoxicity to MCF-7 and Vero cells

References